Coryell W, Noyes R, Reich J
University of Iowa College of Medicine, Department of Psychiatry, Iowa City 52242.
Biol Psychiatry. 1991 Jan 15;29(2):96-102. doi: 10.1016/0006-3223(91)90038-n.
Seventy-seven patients with DSM-III panic disorder underwent a baseline dexamethasone suppression test (DST), participated in an 8-week controlled treatment trial, and provided follow-up interviews 2-4 years later. The 20 patients who had exhibited DST nonsuppression at baseline had more symptoms of anxiety, more work and social disability, and a greater likelihood of ongoing major depression than did patients who had had normal DST results. DST nonsuppression in panic disorder apparently indicates a more persistent and chronically disabling condition.
77名患有精神疾病诊断与统计手册第三版(DSM-III)恐慌症的患者接受了基线地塞米松抑制试验(DST),参与了一项为期8周的对照治疗试验,并在2至4年后接受了随访访谈。与DST结果正常的患者相比,在基线时表现出DST不抑制的20名患者有更多的焦虑症状、更多的工作和社会功能障碍,以及持续患重度抑郁症的可能性更大。恐慌症中的DST不抑制显然表明病情更持久且长期致残。